DiaSorin Molecular Simplexa® Flu A/B & RSV Direct Kit

Simplexa™ Flu A/B & RSV Kit

Reliable detection and differentiation of influenza A virus, influenza B virus and RSV

KIT for Infectious Diseases

Overview

Background

The CDC estimates that influenza has resulted in up to 35.6 million illnesses, 710,000 hospitalizations, and as many as 56,000 deaths annually since 2010.1

Respiratory syncytial virus (RSV) infection is more prevalent in infants and toddlers and is a leading cause of hospitalization in this age group, but RSV also causes disease in adults that can be severe in certain populations.2

1. https://www.cdc.gov/flu/about/disease/burden.htm
2. MOL2650, SimplexaTM Flu A/B & RSV Direct Kit Product Insert, Rev. F.

Why to choose it

Capable of running 94 patient samples at the same time.

Benefits

DiaSorin Molecular Simplexa® Flu A/B & RSV Direct Kit
Detect
92 strains

DiaSorin Molecular is committed to ongoing monitoring and testing of emerging flu strains to ensure the most comprehensive strain coverage

92 strains have been validated, with more strains tested regularly to provide confidence in your results.

CURRENT STRAIN MONITORING
2016/2017 VACCINE STRAINS
2016/2017
vaccine strains
A/California/7/2009
(H1N1)-like virusV
A/Hong Kong/4801/2014
(H3N2)-like virus T
B/Brisbane/60/2008-like virusV
B/Phuket/3073/2013-like virus V*
2017/2018 VACCINE STRAINS
2017/2018
vaccine strains
A/Michigan/45/2015
(H1N1)pdm09-like virusR
A/Hong Kong/4801/2014
(H3N2)-like virus T
B/Brisbane/60/2008-like virusV
B/Phuket/3073/2013-like virus V*
V = Validated and in FDA cleared PI
T = Tested but not submitted to FDA to revise PI
R = Recently ordered from IRR, will be tested
* in quadrivalent vaccine
Reliability

Reliable performance that you can count on

greater than 98% specificity

SimplexaTM Flu A/B & RSV assay has 100% sensitivity and greater than 98% specificity.

SimplexaTM Flu A/B and Culture/DFA Clinical Agreement
Influenza A
Clinical Agreement Prospective
Samples
Retrospective
Samples
Clinical Agreement Sensitivity Prospective
Samples
 100%
Retrospective
Samples
 100%
Clinical Agreement Specificity Prospective
Samples
 99.3%
Retrospective
Samples
 100%
Influenza B
Clinical Agreement Prospective
Samples
Retrospective
Samples
Clinical Agreement Sensitivity Prospective
Samples
 100%
Retrospective
Samples
 100%
Clinical Agreement Specificity Prospective
Samples
 99.8%
Retrospective
Samples
 100%
RSV
Clinical Agreement Prospective
Samples
Retrospective
Samples
Clinical Agreement Sensitivity Prospective
Samples
 98.0%
Retrospective
Samples
 100%
Clinical Agreement Specificity Prospective
Samples
 96.9%
Retrospective
Samples
 96.0%


Ordering info

Product Code Reactions
Product

SimplexaTM Flu A/B & RSV Kit

Code MOL2600 Reactions 100

Our repository

All the answers you need.
Access our database to find:
instructions for use, safety data sheets,
assay protocols and more.

Access our repository